National University of Ireland, Galway, Ireland
universityofgalway.ieTotal trials
46
Active
8
Phase 3
1
Total enrollment
13,691
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Venous Thrombosis4
- Coronary Artery Disease3
- Cardiovascular Diseases3
- Heart Failure2
- Varicose Ulcer2
- Gestational Diabetes2
- Myocardial Ischemia2
- Coronary Disease2
Frequently asked questions about National University of Ireland, Galway, Ireland
- How many clinical trials does National University of Ireland, Galway, Ireland have on ClinicalTrials.gov?
- National University of Ireland, Galway, Ireland is listed as the lead sponsor on 46 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of National University of Ireland, Galway, Ireland's trials are in Phase 3?
- 1 of National University of Ireland, Galway, Ireland's trials are in Phase 3.
- What therapeutic areas does National University of Ireland, Galway, Ireland focus on?
- National University of Ireland, Galway, Ireland's most-studied conditions on ClinicalTrials.gov are Venous Thrombosis, Coronary Artery Disease, Cardiovascular Diseases, Heart Failure, Varicose Ulcer.